MINK
Live / Registered — Registered (as of 17 Feb 2026)
What this means for you
Registered since 17 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90779238
- Registration number
- 8145606
- Mark type
- Stylized text
- Filed
- 17 Jun 2021
- Published for opposition
- 26 Apr 2022
- Registered
- 17 Feb 2026
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; biological preparations, namely, cell therapies for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease
- Class 042 — Scientific and technological services: Pharmaceutical, medical, scientific, and biopharmaceutical research and development
Owner
- MINK THERAPEUTICS, INC., Lexington, MA, US
- MINK THERAPEUTICS, INC., Lexington, MA, US
- MINK THERAPEUTICS, INC., LEXINGTON, MA, US
- AgenTus Therapeutics, Inc., Lexington, MA, US
Prosecution history
- 17 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 27 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Nov 2025 — ASSIGNED TO LIE
- 12 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Aug 2025 — NON-FINAL ACTION E-MAILED
- 12 Aug 2025 — SU - NON-FINAL ACTION - WRITTEN
- 05 Jul 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Jun 2025 — USE AMENDMENT FILED
- 23 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 03 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED